Le Lézard
Classified in: Health
Subjects: MAV, CPG, CFG

/R E P E A T -- NOTICE TO THE MEDIA - The Government of Canada and the Government of British Columbia to make an important announcement in the context of Canada's response to the opioid overdose crisis in British Columbia/


VANCOUVER, BC, May 30, 2022 /CNW/ - The Honourable Carolyn Bennett, Minister of Mental Health and Addictions and Associate Minister of Health, and the Honourable Sheila Malcolmson, British Columbia Minister of Mental Health and Addictions, will make a joint announcement.

There will be a virtual media availability immediately following the announcement.

 

The event will be preceded by a technical briefing, held under embargo.

Date
May 31, 2022

Time

Technical briefing: 9:00 AM PDT
Ministerial event: 11:00 AM PDT

Location

The ministerial event will be for cameras only.

Vancouver Cabinet Office
999 Canada Place, Suite 740
Vancouver, BC

Journalists wishing to join will have the option of attending via Zoom. Please contact [email protected] for registration and to obtain further information.

The technical briefing will be held virtually via Zoom.

Participation in the question and answer portion of the technical briefing event is for accredited members of the Press Gallery only. Media who are not members of the Press Gallery and wish to attend may contact [email protected] for temporary access.

A teleconference line is also available for listening to the technical briefing:

Toll-free dial-in number (Canada/US):
1-866-805--7923

Local dial-in number:
613-960-7518

Participant passcode: 9782242

**The content of the technical briefing will be under embargo until the ministerial event begins.**

NOTE: To help ensure optimal simultaneous interpretation sound quality, journalists are encouraged to use a microphone (headphones/headset) or, when possible, a landline, and to avoid using speaker mode if queuing up for questions.

Twitter: @GovCanHealth
Facebook: Healthy Canadians

SOURCE Health Canada


These press releases may also interest you

at 06:30
Qomolangma Acquisition Corp. (the "Company") announced that it has received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company has not yet filed its Form 10-K for the period ended December 31, 2023,...

at 06:30
Caris Life Sciences® (Caris), the leading next-generation AI TechBio company and precision medicine pioneer, today announced that the company and collaborators from the biopharma industry and leading cancer centers, including those within the Caris...

at 06:13
MolecuLight Inc., the pioneer in point-of-care fluorescence imaging for real-time detection of elevated bacterial loads in wounds, proudly announces the presentation of findings from multiple MolecuLight studies in nine clinical posters at the...

at 06:05
FogPharma®, a clinical-stage biopharmaceutical company dedicated to delivering a new class of therapies that go beyond the limits of currently available medicines using its Helicontm peptide platform, and ARTBIO, Inc. ("ARTBIO"), a clinical-stage...

at 06:05
Rockwell Medical, Inc. (the "Company") , a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced financial and operational results for the...

at 06:05
Aurinia Pharmaceuticals Inc. (Aurinia or the Company), today announced the presentation of results from an updated cost-effective analysis of LUPKYNIS (voclosporin), a second generation calcineurin inhibitor (CNI), at the annual National Kidney...



News published on and distributed by: